Last reviewed · How we verify
NCT06724250
Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.
Phase 4 trial testing Biofeedback therapy in Obstructed Defaecation Syndrome in 78 participants. Completed in 30 September 2024.
31 August 2024
Quick facts
| Lead sponsor | Mansoura University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 78 |
| Start date | 1 August 2023 |
| Primary completion | 31 August 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Biofeedback therapy
- Botulinum Toxin A (Botox ) — full drug profile →
Conditions studied
- Obstructed Defaecation Syndrome — all drugs for Obstructed Defaecation Syndrome →
Sponsor
Mansoura University
Who can join
18 and older, any sex, with Obstructed Defaecation Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
assessment the Improvement symptoms of obstructed defecation after biofeedback training versus botulinum toxin injection
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06724250
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biofeedback therapy
Trials testing the same drug.
- NCT04547816 — Efficacy of Conservative Treatment of Functional Defecatory Disorders in Females With Pelvic Organ Prolapse · Phase 3 · recruiting
- NCT02826096 — A Brief Version of Biofeedback Therapy for Panic Disorder · NA · completed
Other recruiting trials for Obstructed Defaecation Syndrome
Currently open trials in the same condition.
- NCT06804993 — Rectocele Repair with or Without Internal Sphincter Botulinum Toxin Injection: a Prospective Randomized Trial · Phase 4 · active not recruiting
Other Mansoura University trials
Trials by the same sponsor.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
- NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
- NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
- NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06724250 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06724250.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing